These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9109046)

  • 21. Stereoselective pharmacokinetics of methadone in beagle dogs.
    Schmidt N; Brune K; Williams KM; Geisslinger G
    Chirality; 1994; 6(6):492-5. PubMed ID: 7946975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate.
    Hamdy DA; Brocks DR
    Chirality; 2009 Jul; 21(7):704-12. PubMed ID: 18988259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical toxicology of pirmenol hydrochloride.
    Martin RA; de la Iglesia FA
    Am J Cardiol; 1987 Jun; 59(16):10H-14H. PubMed ID: 3591709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics.
    Hammill SC; Shand DG; Routledge PA; Hindman MC; Baker JT; Pritchett EL
    Circulation; 1982 Feb; 65(2):369-75. PubMed ID: 7053896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding profiles of class I antiarrhythmic agents to cardiac muscarinic receptors: competitive and allosteric interactions with the receptors and their pharmacological significance.
    Endou M; Gando S; Hattori Y; Kanno M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):992-8. PubMed ID: 1890628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate.
    Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G
    Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of pirmenol and lidocaine: a placebo-controlled, double-blind, comparative study.
    Nieminen MS; Toivonen L; Manninen V; Frick H
    Am J Cardiol; 1987 Jun; 59(16):27H-32H. PubMed ID: 3296728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of intravenous pirmenol.
    Sanders SW; Nappi JM; Foltz RL; Lutz JR; Anderson JL
    J Clin Pharmacol; 1983; 23(2-3):113-22. PubMed ID: 6853743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective pharmacokinetics of ibuprofen in rats: effect of enantiomer-enantiomer interaction in plasma protein binding.
    Itoh T; Maruyama J; Tsuda Y; Yamada H
    Chirality; 1997; 9(4):354-61. PubMed ID: 9275314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
    Johnson BF; Haffajee CI; Woodman T; Sloan KL
    J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of the enantiomers of mepivacaine after intravenous administration of the racemate in volunteers.
    Burm AG; Cohen IM; van Kleef JW; Vletter AA; Olieman W; Groen K
    Anesth Analg; 1997 Jan; 84(1):85-9. PubMed ID: 8989005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.
    Mehvar R; Brocks DR; Vakily M
    Clin Pharmacokinet; 2002; 41(8):533-58. PubMed ID: 12102640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pirmenol on premature atrial complexes.
    Toivonen LK
    Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measures.
    Mandema JW; Heijligers-Feijen CD; Tukker E; De Boer AG; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):88-95. PubMed ID: 1560387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of gacyclidine enantiomers in plasma and spinal cord after single enantiomer administration in rats.
    Hoizey G; Kaltenbach ML; Dukic S; Lamiable D; Millart H; D'Arbigny P; Vistelle R
    Int J Pharm; 2001 Oct; 229(1-2):147-53. PubMed ID: 11604267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.
    Kwok DW; Kerr CR; McErlane KM
    Xenobiotica; 1995 Nov; 25(10):1127-42. PubMed ID: 8578769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of intravenous pirmenol.
    Morris KG; Phillips HR
    Angiology; 1988 Mar; 39(3 Pt 2):321-6. PubMed ID: 3354931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.